Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Amy Helen Wilson has worked on the following 4 EPO patent applications which have been published in the last five years:

EP13705504

SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES

IPC classification:
C07K 16/00
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amy Helen Wilson, UCB Celltech
Status:
PATENT GRANTED
EP13707824

SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES

IPC classification:
C07K 16/00
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amy Helen Wilson, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP11712495

PD-1 ANTIBODY

IPC classification:
C07K 14/705, C07K 16/28, C07K 16/46, C12N 15/13
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Bernadette Angelina Hambleton, Sterling IP
Agent:
Amy Helen Wilson, UCB Celltech
Status:
GRANT OF PATENT INTENDED
EP11707186

BIOLOGICAL PRODUCTS: HUMANISED AGONISTIC ANTI-PD-1 ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/46, C12N 15/13
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
Amy Helen Wilson, UCB Celltech
Status:
PATENT GRANTED

Please Sign in to use this feature